US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Genomics Market Research Reports & Industry Analysis

Genomics is a field within genetics which covers the science of the genomes of individual organisms The field includes intensive efforts to determine the entire DNA sequence of organisms and fine-scale genetic mapping efforts. The field also includes studies of intragenomic phenomena such as heterosis(outbreeding enhancement, is the improved or increased function of any biological quality in a hybrid offspring), epistasis (where the effects of one gene are modified by one or several other genes, which are sometimes called modifier genes), pleiotropy (hen a single gene influences multiple phenotypic traits.) and other interactions between loci and alleles within the genome.

The examination fo the role of individual genes in various biologic functions is a concern of molecular biology or genetics and is a common topic of today’s medical and biological research. Research of single genes does not fall into the definition of genomics unless the aim of this genetic, pathway, and functional information analysis is to elucidate its effect on, place in, and response to the entire genome's networks.

RSS Feeds

Genomics Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Animal Genetics Market by Type (Canine, Poultry, Porcine, Bovine), Genetic Material (Semen (Bovine Porcine Equine), Embryo (Bovine Equine)), Testing Services (DNA Testing, DNA Typing, Genetic Disease Testing) - Global Forecast to 2021
7/15/2016 | published by: MarketsandMarkets
... animal genetics market is projected to reach USD 5.50 billion by 2021, growing at a CAGR of 8.4% from 2016 to 2021. Growth in this market can be attributed to a number of factors such ...  |  read more...
USD 5,650
Global Genetic disorders Partnering 2010-2016: Deal trends, players and financials
7/1/2016 | published by: Current Partnering
... since 2010. Trends in Genetic Disorders partnering deals Financial deal terms for headline, upfront and royalty by stage of development Genetic Disorders partnering agreement structure Genetic Disorders partnering contract documents Top Genetic Disorders deals by ...  |  read more...
USD 2,995
Perspective: Predicting Market Success in the Life Science Genomics Space
6/29/2016 | published by: IDC
... maturation of genomics in the shadow of the achievement of the $1,000 genome, opportunities to translate research advances in commercial market success are emerging. While the discovery of genome-specific insights that can translate directly into ...  |  read more...
USD 1,500
Global Genomics Industry 2016 Market Research Report
6/12/2016 | published by: 9Dimen Research
... the main countries (United States, Germany, Japan and China). The report firstly introduced the Genomics basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so ...  |  read more...
USD 2,850
Sample Preparation Market by Product (Instruments (Workstations, Liquid Handling Systems), Consumables (Kits, Filters)), Application (Genomics, Proteomics), End Users (Pharmaceutical and Biotechnology, Food and Beverage) - Global Forecast to 2021
6/14/2016 | published by: MarketsandMarkets
... poised to reach USD 7,203.2 million by 2021 from USD 5,512.2 in 2016, growing at a CAGR of 5.5% during the forecast period of 2016 to 2021. Sample preparation involves conversion of samples into a ...  |  read more...
USD 5,650
Conference Documentation: BioBanking
6/21/2016 | published by: SMI Publishing, Ltd
... discussions on relevant and critical issues on how to improve biobanking practices. The proposed changes to the EU Data Protection Regulation will constitute a new legal framework for biobanking operations if and once passed by ...  |  read more...
USD 788.78
DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026
5/23/2016 | published by: Roots Analysis
... However, DNA is not inert. Cells are continuously exposed to several endogenous and exogenous insults that often cause DNA damage. Despite its role in cellular signalling, ROS, a by-product of mitochondrial respiration, is known to ...  |  read more...
USD 2,349
Biochips Market by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), End user (Academics Institutes, Diagnostics Centers), Fabrication Technology (Microarrays, Microfluidics) - Forecast to 20
5/3/2016 | published by: MarketsandMarkets
... of Biochips and Technological Advancements Will Boost the Growth of the Biochips Market The biochips market is expected to reach USD 17.75 billion by 2020 from USD 7.63 billion in 2015, growing at a CAGR ...  |  read more...
USD 5,650
The Global Genetic Testing Market Size, Strategies and Forecasts 2016 to 2020
5/2/2016 | published by: Howe Sound Research
... and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, ...  |  read more...
USD 4,995
Human Biobanking Applications - Global Trends, Estimates And Forecasts, 2014-2020 - Report Focus
5/4/2016 | published by: Axis Research Mind
... perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, ...  |  read more...
USD 480
Human Biobanking Applications Global Trends, Estimates And Forecasts, 2014-2020 - Industry Overview
5/4/2016 | published by: Axis Research Mind
... private initiative for use in biomedical research. Biobanks contain large collections of DNA collected from individuals diagnosed of specific diseases accompanied by detailed health history. Researchers and clinicians investigate biospecimens of specific individuals for indications/diagnosis ...  |  read more...
USD 1,440
Human Biobanking Equipment - Global Trends, Estimates and Forecasts, 2014-2020 - Report Focus
5/4/2016 | published by: Axis Research Mind
... perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, ...  |  read more...
USD 524
Molecular Diagnostics in Infectious Disease Testing
5/1/2016 | published by: TriMark Publications
... molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics--along with the development of microarray devices to measure analytes in ...  |  read more...
USD 5,500
Global CRISPR Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022
4/29/2016 | published by: Occams Business Research & Consultancy
... of number of startups and venture capitalists and showing their interest in infusing money into this technology. Academic and research firms are the main consumers of CRISPR gene editing tool followed by biotechnology companies. The ...  |  read more...
USD 3,900
Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016
4/27/2016 | published by: Global Markets Direct
... depth analysis on Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) targeted pipeline therapeutics. The report provides comprehensive information on the Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119), targeted therapeutics, complete with ...  |  read more...
USD 3,500
Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016
4/27/2016 | published by: Global Markets Direct
... H1 2016’, provides in depth analysis on Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) targeted pipeline therapeutics. The report provides comprehensive information on the Free Fatty Acid Receptor 1 (G-Protein Coupled ...  |  read more...
USD 3,500
KiSS-1 Receptor (G-Protein Coupled Receptor 54 or G-Protein Coupled Receptor OT7T175 or hOT7T175 or Hypogonadotropin-1 or Kisspeptins Receptor or Metastin Receptor or KISS1R or GPR54) - Pipeline Review, H1 2016
4/27/2016 | published by: Global Markets Direct
... ‘KiSS-1 Receptor (G-Protein Coupled Receptor 54 or G-Protein Coupled Receptor OT7T175 or hOT7T175 or Hypogonadotropin-1 or Kisspeptins Receptor or Metastin Receptor or KISS1R or GPR54) - Pipeline Review, H1 2016’, provides in depth analysis on ...  |  read more...
USD 3,500
Human Biobanking Applications Global Trends, Estimates And Forecasts, 2014-2020 - Market Analysis
5/4/2016 | published by: Axis Research Mind
... government databases, company websites, press releases & published research reports are also used for estimates. HUMAN BIOBANKING - GLOBAL Global market for Human Biobanking Application is projected to reach US$37.1 billion by 2020 from an ...  |  read more...
USD 2,880
Human Biobanking Technologies - Global Trends, Estimates and Forecasts, 2014-2020 - Market Analysis
5/4/2016 | published by: Axis Research Mind
... from government databases, company websites, press releases & published research reports are also used for estimates. HUMAN BIOBANKING - GLOBAL Global market for Human Biobanking Technologies is projected to reach US$37.1 billion by 2020 from ...  |  read more...
USD 2,502
Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020 - Market Analysis
5/4/2016 | published by: Axis Research Mind
... from government databases, company websites, press releases & published research reports are also used for estimates. HUMAN BIOBANKING - GLOBAL Global market for Human Biobanking Ownership is projected to reach US$37.1 billion by 2020 from ...  |  read more...
USD 2,496
Cell-Free DNA (cfDNA) Testing Global Market - Forecast to 2022
6/10/2016 | published by: IQ4I Research and Consultancy
... personalized medicine, and improve the quality of life. The groundbreaking discovery of cfDNA in 1948 has opened up to new possibilities in the field of gynecology, oncology, transplantation and infectious diseases. The cell-free DNA testing ...  |  read more...
USD 4,500
In Vitro Toxicology Testing Market by Product, Type (ADME), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (Genomics, Transcriptomics), Method (Cellular Assays), Industry (Pharmaceutical) - Global Forecast to 2021
6/3/2016 | published by: MarketsandMarkets
... toxicology testing market is expected to USD 27.36 billion by 2021 from USD 14.15 billion in 2016, at a CAGR of 14.1% between 2016 and 2021. By product, the market includes assays, reagents & labware, ...  |  read more...
USD 5,650
Biobanks Market Outlook - Market size, segmentation, market share and competitive landscape (2016-2021)
6/1/2016 | published by: Mordor Intelligence LLP
... during the forecast period. Continuous growth in the global biobanks market can be attributed to the vision of personalized medicine. Additionally, the poor productivity rate of the pharmaceutical industry with respect to the new drug ...  |  read more...
USD 500
Human Biobanking Technologies - Global Trends, Estimates and Forecasts, 2014-2020 - Report Focus
5/4/2016 | published by: Axis Research Mind
... perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, ...  |  read more...
USD 471
Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020 - Report Focus
5/4/2016 | published by: Axis Research Mind
... perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, ...  |  read more...
USD 416
< prev 1    3  4  5  6  7  8  9  10